MustGrow Biologics Corp. (TSXV:MGRO)

Market Cap	35.90M
Revenue (ttm)	7.54M
Net Income (ttm)	-6.37M
Shares Out	58.85M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,500
Average Volume	52,731
Open	0.6200
Previous Close	0.6200
Day's Range	0.6100 - 0.6300
52-Week Range	0.5000 - 1.6200
Beta	0.73
RSI	47.51
Earnings Date	Apr 23, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2014
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: MGRO

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.